These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28620092)

  • 1. The Evolution of Clinical Trials in Oncology: Defining Who Benefits from New Drugs Using Innovative Study Designs.
    Goldberg RM; Wei L; Fernandez S
    Oncologist; 2017 Sep; 22(9):1015-1019. PubMed ID: 28620092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational research in clinical trials: the only way forward.
    Eggermont A; Newell H
    Eur J Cancer; 2001 Nov; 37(16):1965. PubMed ID: 11699495
    [No Abstract]   [Full Text] [Related]  

  • 3. Target validation using Phase 0 clinical trials: Promises and pitfalls.
    Angelo LS; Kurzrock R
    Cancer Biol Ther; 2009 Nov; 8(21):2010-2. PubMed ID: 20037466
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversy trails adaptive clinical trials.
    Goozner M
    J Natl Cancer Inst; 2012 Sep; 104(18):1347-8. PubMed ID: 22984199
    [No Abstract]   [Full Text] [Related]  

  • 5. An audience with Tatiana Prowell. Interviewed by Asher Mullard.
    Prowell T
    Nat Rev Drug Discov; 2014 Jun; 13(6):410-1. PubMed ID: 24875091
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethical and Policy Issues for Seamless Phase I Oncology Trials.
    Hutchinson N; Vinarov E; Iasonos A; Kimmelman J
    J Clin Oncol; 2020 Mar; 38(7):669-673. PubMed ID: 31877086
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose-toxicity models in oncology.
    Adamina M; Joerger M
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):201-11. PubMed ID: 21241201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American society of clinical oncology - 45th annual meeting. Part 1.
    Gale S
    IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154
    [No Abstract]   [Full Text] [Related]  

  • 9. American society of clinical oncology - 45th annual meeting. Part 2.
    Lakeram M; Kibble A
    IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155
    [No Abstract]   [Full Text] [Related]  

  • 10. European Commission considers revisions to clinical trials directive.
    Mason E
    J Natl Cancer Inst; 2010 Mar; 102(5):292-4, 297. PubMed ID: 20173121
    [No Abstract]   [Full Text] [Related]  

  • 11. [New therapeutic strategies in oncology].
    Bohuon C
    Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
    [No Abstract]   [Full Text] [Related]  

  • 12. Can single-patient investigational new drug studies hurry slow trains to the fast track?
    Chenoweth D
    Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOP 13: Pharmacokinetic data analysis.
    Onkologie; 2003 Oct; 26 Suppl 6():56-9. PubMed ID: 23570190
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel drugs--miscellaneous category.
    Hosmer WD; Dubinett SM; Garon EB
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S468-9. PubMed ID: 21102242
    [No Abstract]   [Full Text] [Related]  

  • 15. Neoadjuvant trials could speed up drug approvals.
    Peres J
    J Natl Cancer Inst; 2014 Mar; 106(3):dju072. PubMed ID: 24610911
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel clinical trial designs for the development of new antiretroviral agents.
    Mani N; Miller V;
    AIDS; 2012 Sep; 26(14):1847-8. PubMed ID: 22954760
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 18. Adaptive design may hasten clinical trials.
    Schmidt C
    J Natl Cancer Inst; 2007 Jan; 99(2):108-9. PubMed ID: 17227993
    [No Abstract]   [Full Text] [Related]  

  • 19. American Society of Clinical Oncology--44th Annual Meeting. Reports of clinical trial results--part 1.
    Searle B
    IDrugs; 2008 Aug; 11(8):545-6. PubMed ID: 18683083
    [No Abstract]   [Full Text] [Related]  

  • 20. Next steps in clinical trial redesign.
    Nicholas J
    J Natl Cancer Inst; 2012 Jan; 104(2):90-2. PubMed ID: 22215851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.